Clinical Trial Update: PCSK9 Inhibitor and PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy for pMMR/MSS Locally Advanced Rectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating the combination of a PCSK9 inhibitor and a PD-1 inhibitor with neoadjuvant chemoradiotherapy for pMMR/MSS locally advanced rectal …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• PCSK9 inhibitor (PCSK9 inhibitor)
• PD-1 inhibitor

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: Locally Advanced Rectal Cancer (LARC) | Phase 2 | Status: ACTIVE_NOT_RECRUITING